 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdPharmacogenetics
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
| 2007 |
|
| CRA 2007; 194:2 |
EU regulation on advanced therapies. |
| |
|
| 2006 |
|
| CRA 2006; 165:5 |
World Medical Association speaks out on genetics. |
| CRA 2006; 168:7 |
Pharmacogenomic testing and regulation. |
| CRA 2006; 174:7 |
Corautus gene therapy trial placed on clinical hold. |
| |
|
| 2005 |
|
| CRA 2005; 148:6 |
FDA puts X-SCID trials on hold. |
| CRA 2005; 150:1 |
FDA invites pharmacogenomic data submissions. |
| |
|
| 2004 |
|
| CRA 2004;142:11 |
New FDA guidance on the quality of gene therapies in IND
studies. |
| |
|
| 2003 |
|
| CRA 2003: 102:1 |
WHO updates international ethical guidelines for clinical
studies. |
| CRA 2003; 103:6 |
FDA halts gene therapy trials using retroviral vectors. |
| CRA 2003; 106:5 |
FDA discusses steps for re-starting gene therapy trials. |
| CRA 2003; 109:6 |
Effects of genome-based medicine on Japanese medical
regulation. |
| CRA 2003; 110:4 |
Privacy legislation lags behind science. |
| CRA 2003; 113:4 |
Recommendation published on UK retroviral gene therapy
studies. |
| CRA 2003; 113:6 |
Genetics made simple? |
| CRA 2003; 122:5 |
Submission of pharmacogenomic data to the FDA. |
| |
|
| 2002 |
|
| CRA 2002; 84:4 |
Pharmacogentic terminology. |
| CRA 2002: 89:1 |
Guidance for genetic investigation. |
| CRA 2002; 89:3 |
Consent in pharmacogenetics. |
| CRA 2002; 90:1 |
Genetic testing and insurance concerns. |
| CRA 2002; 93:8 |
EU Directive 2001/83/EC revision. |
| CRA 2002; 98:1 |
ICH update: ready for electronic CTD submissions. |
| CRA 2002; 99:5 |
New gene therapy workshop recommendations. |
| |
|
| 2001 |
|
| CRA 2001; 61:4 |
Pharmacogenetics - the way forward. |
| CRA 2001; 62:5 |
Biopharmaceutical industry speaks its mind. |
| CRA 2001; 66:1 |
"Book of Life". |
| CRA 2001; 72:6 |
Pharmacogenetics and the developing world. |
| CRA 2001; 76:2 |
Therapeutic advances using stem cells. |